Cargando…

Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak

As we begin to pass the first peak of the coronavirus pandemic, the backlog of routine gynaecological surgical work is becoming more apparent and continues to build day by day. The potential for further pandemic surges remain; however it is imperative that elective gynaecological surgery is restored...

Descripción completa

Detalles Bibliográficos
Autores principales: Odejinmi, F, Clark, TJ, Mallick, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universa Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431199/
https://www.ncbi.nlm.nih.gov/pubmed/32832926
_version_ 1783571547490877440
author Odejinmi, F
Clark, TJ
Mallick, R
author_facet Odejinmi, F
Clark, TJ
Mallick, R
author_sort Odejinmi, F
collection PubMed
description As we begin to pass the first peak of the coronavirus pandemic, the backlog of routine gynaecological surgical work is becoming more apparent and continues to build day by day. The potential for further pandemic surges remain; however it is imperative that elective gynaecological surgery is restored safely, ethically and in a timely manner. The risks of COVID-19 transmission and potential increased surgical morbidity must be weighed up against the patient’s ongoing symptoms and quality of life. Universal screening and testing of patients attending for routine surgery, as well as staff testing and retesting, will be fundamental to reducing the risks to both patients and staff, and avoiding the higher morbidity encountered when operating on asymptomatic infected patients. The aim of this paper is to explore pathways to safely reintroduce elective benign gynaecological surgery and the challenges that will be encountered including patient counselling and informed consent, surgical prioritisation and the screening and testing of patients and staff, as well as the logistical and ethical challenges of reintroducing benign surgery during COVID-19 times.
format Online
Article
Text
id pubmed-7431199
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Universa Press
record_format MEDLINE/PubMed
spelling pubmed-74311992020-08-20 Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak Odejinmi, F Clark, TJ Mallick, R Facts Views Vis Obgyn Opinion Article As we begin to pass the first peak of the coronavirus pandemic, the backlog of routine gynaecological surgical work is becoming more apparent and continues to build day by day. The potential for further pandemic surges remain; however it is imperative that elective gynaecological surgery is restored safely, ethically and in a timely manner. The risks of COVID-19 transmission and potential increased surgical morbidity must be weighed up against the patient’s ongoing symptoms and quality of life. Universal screening and testing of patients attending for routine surgery, as well as staff testing and retesting, will be fundamental to reducing the risks to both patients and staff, and avoiding the higher morbidity encountered when operating on asymptomatic infected patients. The aim of this paper is to explore pathways to safely reintroduce elective benign gynaecological surgery and the challenges that will be encountered including patient counselling and informed consent, surgical prioritisation and the screening and testing of patients and staff, as well as the logistical and ethical challenges of reintroducing benign surgery during COVID-19 times. Universa Press 2020-08-05 /pmc/articles/PMC7431199/ /pubmed/32832926 Text en Copyright © 2020 Facts, Views & Vision http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion Article
Odejinmi, F
Clark, TJ
Mallick, R
Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title_full Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title_fullStr Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title_full_unstemmed Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title_short Getting back to business: considerations for restarting non-cancer gynaecological surgery following the COVID-19 peak
title_sort getting back to business: considerations for restarting non-cancer gynaecological surgery following the covid-19 peak
topic Opinion Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431199/
https://www.ncbi.nlm.nih.gov/pubmed/32832926
work_keys_str_mv AT odejinmif gettingbacktobusinessconsiderationsforrestartingnoncancergynaecologicalsurgeryfollowingthecovid19peak
AT clarktj gettingbacktobusinessconsiderationsforrestartingnoncancergynaecologicalsurgeryfollowingthecovid19peak
AT mallickr gettingbacktobusinessconsiderationsforrestartingnoncancergynaecologicalsurgeryfollowingthecovid19peak